Assembly Biosciences, Inc. (ASMB) Revenue History
Assembly Biosciences, Inc. (ASMB) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | $9.02M |
| 2018-12-31 | $14.80M |
| 2019-12-31 | $15.96M |
| 2020-12-31 | $79.11M |
| 2021-12-31 | $6.25M |
| 2022-12-31 | $153.00K |
| 2023-12-31 | $7.16M |
| 2024-12-31 | $28.52M |
| 2025-12-31 | $72.30M |
How ASMB compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NTLA | Intellia Therapeutics Inc. | $67.67M |
| NKTR | Nektar Therapeutics | $55.23M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
These are five companies in the same sector as ASMB with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Assembly Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("ASMB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ASMB | $32.13 | +7.06% | 0.48M |
| 3 | ||||
| 4 | ||||
| 5 |